Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06078683 · ClinicalTrials.gov registry record · NA

Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function

A NA study of Type 2 Diabetes and Ketones, Metabolism, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06078683 is a NA study of Type 2 Diabetes and Ketones, Metabolism that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 30 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06078683, a NA study of Type 2 Diabetes and Ketones, Metabolism, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study is being done to evaluate how a ketone ester (KE) supplement affects heart function and health in people with diabetes compared to a placebo supplement (made with standard food ingredients that do not contain ketone esters).

Interventions

  • DIETARY_SUPPLEMENT Ketone Ester Acute
  • DIETARY_SUPPLEMENT Placebo Acute

Study Locations (1)

Ohio

  • The Ross Heart Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-06-06
Est. Completion 2027-08-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT06078683

The ClinicalTrials.gov registry entry for NCT06078683 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Ketone Ester Acute is the first listed.

NCT06078683 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06078683 about?

NCT06078683 is a clinical study titled "Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function". This study is being done to evaluate how a ketone ester (KE) supplement affects heart function and health in people with diabetes compared to a placebo supplement (made with standard food ingredients that do not contain ketone esters).

What is the current status of trial NCT06078683?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-06-06. Estimated completion is 2027-08-31.

What conditions does trial NCT06078683 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Ketones, Metabolism, Ketone Body Metabolism.

What interventions are being tested in trial NCT06078683?

The interventions under investigation include: Ketone Ester Acute (DIETARY_SUPPLEMENT), Placebo Acute (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06078683?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06078683 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.